Venus Medtech (Hangzhou) Class H Goodwill

Venus Medtech (Hangzhou) Class H posts a goodwill of $990M as of June 2026. That compares with $1B in the prior-year period — down 4.9% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Venus Medtech (Hangzhou) Class H's goodwill was $1B. The latest reading is $990M — a 4.9% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Goodwill is one piece of Venus Medtech (Hangzhou) Class H's financial statement story. At $990M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for VMTHF's goodwill usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Venus Medtech (Hangzhou) Class H's other metric pages and overview cover the third.